Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Casey who wrote (352)	4/2/1998 3:57:00 PM
From: Jon Smith	Read Replies (1) \| Respond to of 1185

If memory serves me correctly, they have 810,000 warrants at an exercise price of $2.00. I believe that they have a 2 year life span. I don't think CCM will exercise these warrants just because "they are in the money". Bear in mind that CCM is a company that purchased stock out of the open market, and that they hold 20% of Nortran stock. This would make them an insider, as such they would have to file any transactions bought or sold. CCM invested in Nortran because they saw the value of this company early on. I think they will hold their warrants until the time is right to sell not only for CCM but for NRT as well. It does not cost CCM anything to hold onto their warrants, and by selling them now they could leave a large amount of money on the table.